Clinical trial
A Phase II Study of sEphB4-HSA in Kaposi Sarcoma
NCT02799485 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of sEphB4-HSA in Kaposi Sarcoma
- Lead sponsor
- AIDS Malignancy Consortium
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 13, 2018
- Completion date
- February 19, 2025
- Enrollment
- 23 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
skin kaposi sarcoma